SRC and neoplasm: The xenograft tumor studies have indicated that targeting MCT-1 decreases the active phosphorylated Src and p190B in vivo (Figure 6d), suggesting that MCT-1 controls cancer cell propagation and tumor progression via Src/p190B signaling amplification.